Clinical outcomes following intravitreal methotrexate for primary vitreoretinal lymphoma

PURPOSE: To describe the visual acuity and anatomic outcomes of intravitreal methotrexate (MTX) for the treatment of primary vitreoretinal lymphoma (PVRL). METHODS: Single-center retrospective case series of patients with a diagnosis of PVRL treated with intravitreal MTX. Patient records were review...

Descripción completa

Detalles Bibliográficos
Autores principales: Anthony, Casey L., Bavinger, J. Clay, Shantha, Jessica G., O’Keefe, Ghazala D., Pearce, William A., Voloschin, Alfredo, Grossniklaus, Hans E., Yeh, Steven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645085/
https://www.ncbi.nlm.nih.gov/pubmed/34863313
http://dx.doi.org/10.1186/s40942-021-00346-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645085/
https://www.ncbi.nlm.nih.gov/pubmed/34863313
http://dx.doi.org/10.1186/s40942-021-00346-0

Ejemplares similares